Showing results (281-290 of 401) with videos related to
Sort By:
Pageof 41
The Oncologist|May 31, 2015
Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young WomenLaura C Collins, Shari Gelber, Jonathan D Marotti, et al.Breast (Edinburgh, Scotland)|March 28, 2016
Second international consensus guidelines for breast cancer in young women (BCY2)Shani Paluch-Shimon, Olivia Pagani, Ann H Partridge, et al.Annals of Surgery|December 15, 2022
Local/Regional Recurrence Rates After Breast-Conserving Therapy in Patients Enrolled in Legacy Trials of the Alliance for Clinical Trials in Oncology (AFT-01)Jessica R Schumacher, Alyssa A Wiener, Caprice C Greenberg, et al.Cancer Treatment Reviews|January 24, 2025
Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussionStavroula L Kastora, Eirini Pantiora, Yong Hwa Hong, et al.JAMA|April 29, 2024
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized TrialWendy Y Chen, Karla V Ballman, Ann H Partridge, et al.Cancer|March 23, 2023
Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohortsAnna Weiss, Olga Martínez-Sáez, Adrienne G Waks, et al.The British Journal of Surgery|August 30, 2024
Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort studySabrina M Wang, Yan Li, Amanda Nash, et al.Journal of Cancer Survivorship : Research and Practice|July 15, 2024
Association of cancer treatment with excess heart age among five-year young breast cancer survivorsJacqueline B Vo, Shoshana Rosenberg, Bessie X Zhang, et al.JAMA Surgery|September 1, 2021
Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast CancerLaura Dominici, Jiani Hu, Yue Zheng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapyHarold J Burstein, Leroy M Parker, Aparna Keshaviah, et al.Pageof 41